In 1854, a devastating cholera outbreak gripped London’s Soho district, claiming numerous lives within days. At the time, medical experts believed that “bad air” or miasma caused the disease.
However, one doctor, John Snow, thought differently. Seeking a more scientific explanation, Snow began mapping the cholera cases—a groundbreaking move that would mark the birth of data-driven health analysis, said Corlytics.
As he plotted each case onto a map, Snow noticed clusters forming around the Broad Street water pump. His investigation revealed that contaminated water, not air, was to blame. Interestingly, data also showed that women and children were disproportionately affected.
Florence Nightingale, the pioneering nurse, treated many of these victims and contributed to the understanding of the outbreak. Upon further study, Snow discovered that men, who drank beer instead of water due to workplace allowances, had largely avoided the disease. Once the pump handle was removed, infection rates rapidly declined, proving that data visualisation could save lives.
Fast forward 170 years, and data continues to be at the heart of health and life sciences innovation. Today, AI diagnostics, genomic sequencing, and real-time patient monitoring have transformed medicine. Yet, the principle remains the same—insight through data visualisation. Modern tools have replaced Snow’s dots with complex data models and advanced analytics, creating a new frontier for understanding risk and prevention.
This is where Corlytics comes in. Much like Snow’s cholera map, Corlytics’ regulatory intelligence solutions illuminate unseen patterns—only this time, in the complex landscape of global health and life sciences regulation. Each regulatory notice, enforcement action, or policy update is treated as a “dot” on a modern compliance map. When connected and analysed, these data points reveal emerging regulatory trends, highlight areas of risk concentration, and identify where compliance frameworks may need strengthening.
Corlytics enables firms to transition from reactive compliance to predictive insight—helping them spot potential “Broad Street pumps” before crises occur. Its platform uses machine learning, regulatory taxonomy, and expert analysis to turn fragmented data into a coherent risk narrative. This empowers organisations to make evidence-based compliance and risk decisions amid ever-changing regulatory requirements.
Regulators themselves are now harnessing the power of data and AI. Initiatives such as the European Medicines Agency’s (EMA) Data Analysis and Real World Interrogation Network (DARWIN) and the U.S. Food and Drug Administration’s (FDA) Sentinel System reflect a growing emphasis on data-driven oversight. Corlytics aligns with this evolution, providing institutions with the tools to navigate a dynamic, information-rich regulatory ecosystem.
Just as John Snow’s map turned mystery into prevention, Corlytics transforms regulatory complexity into actionable intelligence, enabling safer, smarter, and more compliant innovation. The replica of the Broad Street pump still stands today—a reminder that every major breakthrough starts with the same question: “What does the data tell us, and what will we do about it?”
Corlytics believes that understanding risk through data is the foundation of better decision-making, safer systems, and healthier outcomes.
Find more on RegTech Analyst.
Copyright © 2025 FinTech Global
